GlassScriptPhysician profile
Steven C Hobbs
NPI 1639386832
$839.97
in general payments reported to CMS, 2019-2025
11 companies · $66.04 in 2025
The $66.04 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $98.49 · 2020: $29.42 · 2021: $338 · 2022: $131 · 2023: $61.73 · 2024: $115 · 2025: $66.04.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $225 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $225.27 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $242.12 | 2021 | |
| Allergan, INC. | $133.80 | 2019-2022 | |
| Rxsight INC | $97.50 | 2024 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Horizon Therapeutics Plc | $95.39 | 2021 | |
| Kala Pharmaceuticals, INC. | $69.87 | 2019-2020 | |
| Apellis Pharmaceuticals, INC. | $66.04 | 2025 | Syfovre |
| Sun Pharmaceutical Industries INC. | $61.73 | 2023 | Cequa |
| Mallinckrodt Hospital Products INC. | $27.27 | 2022 | |
| Bausch & Lomb Americas INC. | $17.84 | 2024 | Miebo |
| Abbvie INC. | $14.44 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $13.97 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Hobbs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.